Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Weiss

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Research Administration|August 23, 2019
Assessing Research Collaboration through Co-authorship Network AnalysisJesse Fagan, Katherine S Eddens, Jennifer Dolly, et al.
Chest|January 16, 2003
Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokersChandrika J Piyathilake, Andra R Frost, Upender Manne, et al.
Journal of the National Cancer Institute|June 17, 2004
Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancerJiang Shou, Suleiman Massarweh, C Kent Osborne, et al.
International Journal of Cancer|February 22, 2002
Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal womenLynya I Talley, William E Grizzle, John W Waterbor, et al.
The Journal of Biological Chemistry|October 30, 2010
Characterization of promoter elements regulating the expression of the human neurotensin/neuromedin N geneXiaofu Wang, Pat Gulhati, Jing Li, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2003
Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancerMartin J Heslin, Jieming Yan, Heidi Weiss, et al.
Breast Cancer Research and Treatment|October 12, 2012
A prognostic model of early breast cancer relapse after standard adjuvant therapy and comparison with metastatic disease on initial presentationLi Chen, Edward Romond, Saurin Chokshi, et al.
Journal of the National Cancer Institute|September 8, 2005
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistanceGrazia Arpino, Heidi Weiss, Adrian V Lee, et al.
Leukemia Research|October 1, 2013
A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemiaDianna S Howard, Jane Liesveld, Gordon L Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lungChandrika J Piyathilake, Andra R Frost, Uppender Manne, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Research Administration|August 23, 2019
Assessing Research Collaboration through Co-authorship Network AnalysisJesse Fagan, Katherine S Eddens, Jennifer Dolly, et al.
Chest|January 16, 2003
Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokersChandrika J Piyathilake, Andra R Frost, Upender Manne, et al.
Journal of the National Cancer Institute|June 17, 2004
Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancerJiang Shou, Suleiman Massarweh, C Kent Osborne, et al.
International Journal of Cancer|February 22, 2002
Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal womenLynya I Talley, William E Grizzle, John W Waterbor, et al.
The Journal of Biological Chemistry|October 30, 2010
Characterization of promoter elements regulating the expression of the human neurotensin/neuromedin N geneXiaofu Wang, Pat Gulhati, Jing Li, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2003
Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancerMartin J Heslin, Jieming Yan, Heidi Weiss, et al.
Breast Cancer Research and Treatment|October 12, 2012
A prognostic model of early breast cancer relapse after standard adjuvant therapy and comparison with metastatic disease on initial presentationLi Chen, Edward Romond, Saurin Chokshi, et al.
Journal of the National Cancer Institute|September 8, 2005
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistanceGrazia Arpino, Heidi Weiss, Adrian V Lee, et al.
Leukemia Research|October 1, 2013
A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemiaDianna S Howard, Jane Liesveld, Gordon L Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lungChandrika J Piyathilake, Andra R Frost, Uppender Manne, et al.
Pageof 6